TheraRadar
← Back
Data updated: Jul 17, 2026

ZHEJIANG YONGNING PHARMACEUTICAL CO LTD

Pharma
Pharmaceuticals

ZHEJIANG YONGNING PHARMACEUTICAL CO LTD is a pharmaceutical company with 1 FDA-approved products.

-
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

ZHEJIANG YONGNING PHARMACEUTICAL CO LTD's Key Drugs

ZHEJIANG YONGNING PHARMACEUTICAL CO LTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

ZHEJIANG YONGNING PHARMACEUTICAL CO LTD's Recent FDA Approvals

New NDA/BLA approvals for ZHEJIANG YONGNING PHARMACEUTICAL CO LTD over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

ZHEJIANG YONGNING PHARMACEUTICAL CO LTD's Therapeutic Areas

Disease areas where ZHEJIANG YONGNING PHARMACEUTICAL CO LTD has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

ZHEJIANG YONGNING PHARMACEUTICAL CO LTD Pipeline Snapshot

Active clinical trials for ZHEJIANG YONGNING PHARMACEUTICAL CO LTD across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • Top drug revenue breakdown
  • Drug-level revenue analysis

Trial Catalysts

  • Active trial monitoring
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling